NTLA   $13.87  2.36% Market Closed After Close 13.87 0.0

Intellia Therapeutics, Inc.
Total Cash 691.07M
totalCashPerShare 6.803
EBITDA -514.18M
Total Debt 106.30M
quickRatio 6.693
currentRatio 7.205
Total Revenue 45.97M
debtToEquity 10.946
Revenue/Share 0.495
ROA -0.26048002
ROE -0.49018002
grossProfits
freeCashflow -213.18M
operatingCashflow -373.28M
earningsGrowth
revenueGrowth -0.488
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -19.98606
profitMargins 0.0
enterpriseValue 982.59M
forwardPE -2.862745
floatShares 100.30M
sharesOutstanding 101.58M
sharesShort 16.36M
sharesShortPriorMonth 14.76M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.88%
Short Ratio help_outline 9.55%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 9.88
Price To Book help_outline 1.63
earningsQuarterlyGrowth
netIncomeToCommon -508.80M
trailingEps -5.48%
forwardEps -5.61%
enterpriseToEbitda -1.91
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.38 3Q 2024
institutionsCount 419
lastUpdated Nov. 7, 2024, 2:27 a.m.